Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20230 | 407 | 29.8 | 53% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
662 | 12640 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DUODENAL DISTENSION | Author keyword | 20 | 100% | 2% | 9 |
2 | KATEDRA FIZJOL BIOCHEM FARMAKOL TOKSYKOL | Address | 4 | 67% | 1% | 4 |
3 | EXPT CLIN PHYSIOPHARMACOL | Address | 4 | 75% | 1% | 3 |
4 | H 3NITRENDIPINE BINDING | Author keyword | 2 | 50% | 1% | 3 |
5 | CALCIUM MAGNESIUM SOFTGELS | Author keyword | 1 | 100% | 0% | 2 |
6 | CLONIXIN | Author keyword | 1 | 50% | 0% | 2 |
7 | NEUROPHYSIOL BIOPHYS UNIT | Address | 1 | 100% | 0% | 2 |
8 | PHYSIOL ANIM FEEDING | Address | 1 | 100% | 0% | 2 |
9 | RETICULO RUMINAL CONTRACTIONS | Author keyword | 1 | 100% | 0% | 2 |
10 | 5HT RECEPTOR SUBTYPES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIHYDROPYRIDINE BINDING SITES | 4 | 33% | 3% | 11 |
2 | DUODENAL DISTENSION | 4 | 46% | 1% | 6 |
3 | ADMINISTERED AMINOGLYCOSIDE ANTIBIOTICS | 3 | 57% | 1% | 4 |
4 | H 3 NITRENDIPINE BINDING | 2 | 32% | 1% | 6 |
5 | DIHYDROPYRIDINE BINDING | 2 | 17% | 2% | 8 |
6 | ACTION POTENTIAL PRODUCTION | 1 | 100% | 0% | 2 |
7 | INTRATHECALLY ADMINISTERED CALCIUM | 1 | 50% | 0% | 2 |
8 | CATION CHELATORS | 1 | 50% | 0% | 1 |
9 | CONCURRENT NIMODIPINE | 1 | 50% | 0% | 1 |
10 | CONOTOXIN GVIA BINDING | 0 | 20% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Involvement of calcium in pain and antinociception | 2001 | 27 | 51 | 63% |
Voltage-gated calcium channel blockers as potential analgesics for humans and animals | 2005 | 0 | 29 | 66% |
Spinal morphine/clonidine antinociceptive synergism: Involvement of G proteins and N-type voltage-dependent calcium channels | 1996 | 32 | 95 | 21% |
Neuropharmacological basis of stress moderation | 2001 | 5 | 18 | 28% |
INTERACTIONS BETWEEN ANALGESICS AND CALCIUM-CHANNEL BLOCKERS | 1990 | 20 | 36 | 33% |
POSSIBLE MECHANISMS OF MORPHINE ANALGESIA | 1991 | 73 | 47 | 13% |
MECHANISMS OF RECEPTOR-MEDIATED MODULATION OF TRANSMITTER RELEASE IN NORADRENERGIC, CHOLINERGIC AND SENSORY NEURONS | 1986 | 100 | 134 | 14% |
OPIATES, 2ND MESSENGERS AND CELL RESPONSE | 1983 | 52 | 46 | 28% |
INTERACTIONS BETWEEN CALCIUM-CHANNEL BLOCKERS AND NON-CARDIOVASCULAR DRUGS - INTERACTIONS WITH DRUGS ACTING AT THE NEUROMUSCULAR OR THE CNS LEVEL | 1988 | 9 | 41 | 24% |
THE MECHANISM OF ACTION OF OPIATES IN REGULATING NORADRENALINE RELEASE | 1982 | 3 | 4 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KATEDRA FIZJOL BIOCHEM FARMAKOL TOKSYKOL | 4 | 67% | 1.0% | 4 |
2 | EXPT CLIN PHYSIOPHARMACOL | 4 | 75% | 0.7% | 3 |
3 | NEUROPHYSIOL BIOPHYS UNIT | 1 | 100% | 0.5% | 2 |
4 | PHYSIOL ANIM FEEDING | 1 | 100% | 0.5% | 2 |
5 | MED SCI CARDIOVASC | 1 | 50% | 0.2% | 1 |
6 | PRACOWNIA FIZJO FARMAKOL DOSWIADCZALNEJ | 1 | 50% | 0.2% | 1 |
7 | RAZI HERBAL MEDICINES | 1 | 50% | 0.2% | 1 |
8 | UNIT ENVIRONM PHYSIOL | 1 | 50% | 0.2% | 1 |
9 | UNIV VET MED JU AU | 1 | 50% | 0.2% | 1 |
10 | ZAKLAD ENDOKRYNOL POROWNAWCZEJ | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000220642 | ZHUMERIA MAJDAE//GOSSYPIN//SECURIGERA SECURIDACA |
2 | 0.0000181690 | SR 33557//SR33805//H 3PN200 110 |
3 | 0.0000165345 | MORPHINE WITHDRAWAL//EQUIP CELLULAR MOL PHARMACOL//ACUTE DEPENDENCE |
4 | 0.0000165035 | ANAESTHETIC TECHNIQUES REGIONAL INTRATHECAL//IONS POTASSIUM CHLORIDE//PHARMACOLOGY MAGNESIUM SULPHATE LIGNOCAINE |
5 | 0.0000135134 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
6 | 0.0000104402 | CHICK SYMPATHETIC NEURONS//RABBIT HIPPOCAMPUS//PRESYNAPTIC ALPHA 2 ADRENOCEPTORS |
7 | 0.0000095241 | ADENOSINE PHARMACOLOGY//ANESTHESIA VOLATILE ISOFLURANE NITROUS OXIDE//NBTI SENSITIVE ADENOSINE TRANSPORTER |
8 | 0.0000091226 | 5 NITROFURANTOIN//BENCHMARK DOSE MODELLING//SALSOLA OPPOSITIFOLIA DESF |
9 | 0.0000084207 | CA2 ANTAGONISTIC ACTION//INNOVAT PATHOPHYSIOL GRP//RAT PHRENIC NERVE |
10 | 0.0000074287 | SLAFRAMINE//RUMINAL CONTRACTIONS//RHIZOCTONIA LEGUMINICOLA |